Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation. | Am J Transl Res | 2024 | 39822558 | PubTator, text mining | PubMed |
| Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer. | Sci Rep | 2024 | 39733078 | PubTator, text mining | PubMed |
| Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model. | Heliyon | 2024 | 39687194 | PubTator, text mining | PubMed |
| Prognostic value of ubiquitination-related differentially expressed genes in esophageal squamous cell carcinoma: a comprehensive analysis and future directions. | J Thorac Dis | 2024 | 39678832 | PubTator, text mining | PubMed |
| Detection of Genetic Variations in Children with Tetralogy of Fallot Using Whole Exome Sequencing Technology Integrated Bioinformatics Analysis. | Genet Test Mol Biomarkers | 2024 | 39653367 | PubTator, text mining | PubMed |
| Exploring the Target Genes of Fucosylated Chondroitin Sulfate in Treating Lung Adenocarcinoma Based on the Integration of Bioinformatics Analysis, Molecular Docking, and Experimental Verification. | ACS Omega | 2024 | 39583738 | PubTator, text mining | PubMed |
| Identification and Validation of Telomere-Related Gene Signature in Intervertebral Disc Degeneration. | Cureus | 2024 | 39553152 | PubTator, text mining | PubMed |
| Self-priming of Plk1 binding to BubR1 ensures accurate mitotic progression. | Commun Biol | 2024 | 39516273 | PubTator, text mining | PubMed |
| BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer. | Semin Cancer Biol | 2024 | 39490401 | PubTator, text mining | PubMed |
| Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis. | Medicine (Baltimore) | 2024 | 39470543 | PubTator, text mining | PubMed |
| Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis. | Med Oncol | 2024 | 39352464 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals that defects in cell cycle regulation contribute to preimplantation embryo arrest. | Genomics | 2024 | 39326642 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis reveals the gene signatures, epigenetic roles, and regulatory networks in endometriosis. | Eur J Obstet Gynecol Reprod Biol | 2024 | 39306912 | PubTator, text mining | PubMed |
| Multifaceted roles of SUMO in DNA metabolism. | Nucleus | 2024 | 39287196 | PubTator, text mining | PubMed |
| Identification of key regulatory genes in the pathogenesis of COVID-19 and sepsis: An observational study. | Medicine (Baltimore) | 2024 | 39259097 | PubTator, text mining | PubMed |
| Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts. | Exp Eye Res | 2024 | 39243928 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients. | J Gastrointest Cancer | 2024 | 39240276 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses. | Sci Rep | 2024 | 39169044 | PubTator, text mining | PubMed |
| Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. | Med Oncol | 2024 | 39115587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=9